Drug traceability is focus of forum in the Federal Senate
Source: Brazilian Medical Association - SP - 20/08/2009
Counterfeiting and the need to improve mechanisms for traceability and authenticity of medicines in the country will be a central theme of the National System of Medicines Control System, to be held this Thursday, August 20, in the auditorium Senador Antonio Carlos Magalhães - located at Interlegis, Federal Senate. The National Medicines Control System, established by law 11.903, on January 15 of this year, consists of a program to monitor all medicines produced, dispensed and sold in Brazil and provides for the monitoring of products throughout its production chain , from manufacture to consumption by the population. The National Health Surveillance Agency (Anvisa) will be responsible for the implementation and coordination of the new system.
At the Forum, there will be presence, as speakers, representatives of the Federal Government, legislative, executive, pharmaceutical industries, third sector, among others, indispensable for fostering the debate. Names like Dirceu Raposo (ANVISA), André Franco Montoro Filho (ETCO), Ciro Mortella (Febrafarma), Vanessa Grazziotin (federal deputy |), André Barcellos (National Council to Combat Piracy and Intellectual Property Offenses) are confirmed at the event (check the complete schedule at the end of the release).
The control of medications must be carried out by means of an identification system, with the use of technologies for the capture, storage and electronic transmission of data. The implementation will be done gradually and within three years.
According to the CEO of ANVISA, the new system will make the unique identification of each medicine box, functioning as an RG for the product, in addition to also providing information regarding the lot and the expiration date. He also explains that the improvements instituted by the system should not imply an increase in the cost of medicines. “The control of medicines in Brazil will reach levels of excellence, guaranteeing, in addition to traceability, effective monitoring of the use of these products”, he emphasizes.
For federal deputy Vanessa Grazziotin (PCdoB-AM), author of the bill that created the National Medicines System, the sanction of the bill means an advance for the country's public health: “with the publication of the law, we will have effective control of what is prescribed and consumed of medicines, thus being able to prevent theft, smuggling and counterfeiting ”. Still according to the parliamentarian, the system will allow to direct the supply policies more efficiently and outline the Brazilian health profile, based on what the population consumes.
Source: CFM
RELATED
Drug traceability is focus of forum in the Federal Senate
Source: Brazilian Medical Association - SP - 20/08/2009
Counterfeiting and the need to improve mechanisms for traceability and authenticity of medicines in the country will be a central theme of the National System of Medicines Control System, to be held this Thursday, August 20, in the auditorium Senador Antonio Carlos Magalhães - located at Interlegis, Federal Senate. The National Medicines Control System, established by law 11.903, on January 15 of this year, consists of a program to monitor all medicines produced, dispensed and sold in Brazil and provides for the monitoring of products throughout its production chain , from manufacture to consumption by the population. The National Health Surveillance Agency (Anvisa) will be responsible for the implementation and coordination of the new system.
At the Forum, there will be presence, as speakers, representatives of the Federal Government, legislative, executive, pharmaceutical industries, third sector, among others, indispensable for fostering the debate. Names like Dirceu Raposo (ANVISA), André Franco Montoro Filho (ETCO), Ciro Mortella (Febrafarma), Vanessa Grazziotin (federal deputy |), André Barcellos (National Council to Combat Piracy and Intellectual Property Offenses) are confirmed at the event (check the complete schedule at the end of the release).
The control of medications must be carried out by means of an identification system, with the use of technologies for the capture, storage and electronic transmission of data. The implementation will be done gradually and within three years.
According to the CEO of ANVISA, the new system will make the unique identification of each medicine box, functioning as an RG for the product, in addition to also providing information regarding the lot and the expiration date. He also explains that the improvements instituted by the system should not imply an increase in the cost of medicines. “The control of medicines in Brazil will reach levels of excellence, guaranteeing, in addition to traceability, effective monitoring of the use of these products”, he emphasizes.
For federal deputy Vanessa Grazziotin (PCdoB-AM), author of the bill that created the National Medicines System, the sanction of the bill means an advance for the country's public health: “with the publication of the law, we will have effective control of what is prescribed and consumed of medicines, thus being able to prevent theft, smuggling and counterfeiting ”. Still according to the parliamentarian, the system will allow to direct the supply policies more efficiently and outline the Brazilian health profile, based on what the population consumes.
Source: CFM
